表紙:注射剤の世界市場 - 考察と予測、COVID-19の潜在的影響:2021年~2025年
市場調査レポート
商品コード
1011013

注射剤の世界市場 - 考察と予測、COVID-19の潜在的影響:2021年~2025年

Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)

出版日: | 発行: Koncept Analytics | ページ情報: 英文 127 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
注射剤の世界市場 - 考察と予測、COVID-19の潜在的影響:2021年~2025年
出版日: 2021年06月14日
発行: Koncept Analytics
ページ情報: 英文 127 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の注射剤市場は、2025年には7,596億1,000万米ドルに達し、2021年~2025年のCAGRで10.95%の成長が予測されています。高齢者人口の増加、利便性の高いドラッグデリバリーに対する需要の高まり、生物学的製剤の使用拡大、医療費の増加、がん患者の急増などの要因が、市場の成長を促進すると予想されます。

当レポートでは、世界の注射剤市場について調査分析し、セグメント別の市場分析、主要地域・主要国市場、市場力学、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 市場概要

  • イントロダクション
  • 薬物投与の非経口経路
  • 非経口投与経路の種類
  • 注射剤の処方
  • 注射剤の吸収に有利な要因
  • 注射剤製品の種類
  • 注射剤の利点

第2章 COVID-19の影響

  • 注射剤の研究開発パイプラインへの投資の拡大
  • 血漿療法の採用の急増
  • スマートシリンジの使用の増加
  • ワクチン生産の加速

第3章 世界の市場分析

  • 世界の注射剤市場:金額別
  • 世界の注射剤市場予測:金額別
  • 世界の注射剤市場:タイプ別
    • イノベーター
    • ジェネリック
    • 抗感染
    • 抗腫瘍 + 免疫調節
    • 消化管 + 代謝
    • 血液関連
    • 中枢神経系
    • 筋骨格系
  • 世界の注射剤市場:地域別
  • 世界のジェネリック注射剤市場:地域別

第4章 地域別の市場分析

  • 北米
  • 欧州
  • 中国
  • インド
  • その他の地域

第5章 市場力学

  • 成長促進要因
  • 主な動向と発展
  • 課題

第6章 競合情勢

  • 世界市場
    • 主要企業の収益比較
    • 主要企業の時価総額の比較
    • 主要企業の研究開発比較
  • 北米市場
    • 米国のジェネリック注射剤市場の金額シェア:主要企業別
    • 米国のジェネリック注射剤市場の数量シェア:主要企業別

第7章 企業プロファイル

  • Novartis International AG
  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • Shanghai Fosun Pharmaceutical Group Co. Ltd.(Gland Pharma Ltd.)
  • Hikma Pharmaceuticals PLC
図表

List of Figures

  • Routes of Drug Administration
  • Types of Parenteral Routes of Administration
  • Factors Favoring the Absorption of Injectable Drugs
  • Types of Injectable Drug Products
  • Advantages of Injectable Drugs
  • Percentage of Drugs in R&D Pipeline Worldwide by Delivery Route (2020)
  • Global Plasma Therapy Market Forecast (2019-2024)
  • Global Smart Syringes Market (2018-2027)
  • Reported Vaccine Production Capacity (Q4 2020-2023)
  • Global Injectables Market by Value (2016-2020)
  • Global Injectables Market Forecast by Value (2021-2025)
  • Global Injectables Market by Type (2020)
  • Global Innovator Injectables Market by Value (2016-2020)
  • Global Innovator Injectables Market Forecast by Value (2021-2025)
  • Global Generic Injectables Market by Value (2016-2020)
  • Global Generic Injectables Market Forecast by Value (2021-2025)
  • Global Generic Injectables Market by Therapy (2020)
  • Global Anti-Infective Injectables Market by Value (2016-2020)
  • Global Anti-Infective Injectables Market Forecast by Value (2021-2025)
  • Global Antineoplastic+ Immunomodulator Injectables Market by Value (2016-2020)
  • Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value (2021-2025)
  • Global Alimentary Tract + Metabolic Injectables Market by Value (2016-2020)
  • Global Alimentary Tract + Metabolic Injectables Market Forecast by Value (2021-2025)
  • Global Blood Related Injectables Market by Value (2016-2020)
  • Global Blood Related Injectables Market Forecast by Value (2021-2025)
  • Global Central Nervous System Injectables Market by Value (2016-2020)
  • Global Central Nervous System Injectables Market Forecast by Value (2021-2025)
  • Global Musculoskeletal Injectables Market by Value (2016-2020)
  • Global Musculoskeletal Injectables Market Forecast by Value (2021-2025)
  • Global Injectables Market by Region (2020)
  • Global Generic Injectables Market by Region (2020)
  • North America Injectables Market by Value (2016-2020)
  • North America Injectables Market Forecast by Value (2021-2025)
  • North America Generic Injectables Market Forecast by Value (2020-2025)
  • The U.S. Injectables Market by Value (2016-2020)
  • The U.S. Injectables Market Forecast by Value (2021-2025)
  • The U.S. Injectables Market by Type (2020)
  • The U.S. Innovator Injectables Market Forecast by Value (2020-2025)
  • The U.S. Generic Injectables Market Forecast by Value (2020-2025)
  • Europe Injectables Market by Value (2016-2020)
  • Europe Injectables Market Forecast by Value (2021-2025)
  • Europe Generic Injectables Market Forecast by Value (2020-2025)
  • China Injectables Market by Value (2016-2020)
  • China Injectables Market Forecast by Value (2021-2025)
  • China Injectables Market by Type (2020)
  • China Generic Injectables Market Forecast by Value (2020-2025)
  • China Innovator Injectables Market Forecast by Value (2020-2025)
  • India Injectables Market by Value (2016-2020)
  • India Injectables Market Forecast by Value (2021-2025)
  • India Generic Injectables Market Forecast by Value (2020-2025)
  • RoW Injectables Market by Value (2016-2020)
  • RoW Injectables Market Forecast by Value (2021-2025)
  • RoW Generic Injectables Market Forecast by Value (2020-2025)
  • Global Population 65 Years and Above (2016-2020)
  • Global Spending on Injectables (2015 v/s 2020)
  • Global Biologics Market Revenue (2016-2022)
  • Global Healthcare Expenditure Per Capita (2016-2020)
  • Global Cancer Prevalence (2018-2023)
  • Global Diabetes Prevalence (2010-2045)
  • Distribution of the Global Injectable Drug Delivery Market by Device (2016 v/s 2025)
  • Percentage of New Drug Shortages in the U.S. (2016-2020)
  • The U.S. Generic Injectables Market Value Share by Key Players (2020)
  • The U.S. Generic Injectables Market Volume Share by Key Players (2020)
  • Novartis International AG Net Sales and Net Income (2016-2020)
  • Novartis International AG Net Sales by Segment (2020)
  • Novartis International AG Net Sales by Region (2020)
  • Pfizer Inc. Total Revenue and Net Income (2016-2020)
  • Pfizer Inc. Revenue by Region (2020)
  • Fresenius SE & Co. KGaA Sales and Net Income (2016-2020)
  • Fresenius SE & Co. KGaA Sales by Segment (2020)
  • Fresenius SE & Co. KGaA Sales by Region (2020)
  • Baxter International Inc. Net Sales and Net Income (2016-2020)
  • Baxter International Inc. Net Sales by Region (2020)
  • Shanghai Fosun Pharmaceutical Group Co. Ltd. Revenue and Profit (2016-2020)
  • Shanghai Fosun Pharmaceutical Group Co. Ltd. Revenue by Segment (2020)
  • Shanghai Fosun Pharmaceutical Group Co. Ltd. Revenue by Region (2020)
  • Hikma Pharmaceuticals PLC Revenue and Profit (2016-2020)
  • Hikma Pharmaceuticals PLC Revenue by Segment (2020)
  • Hikma Pharmaceuticals PLC Revenue by Region (2020)

List of Tables

  • Revenue Comparison of Key Players (2020)
  • Market Capitalization Comparison of Key Players (2021)
  • R&D Comparison of Key Players (2020)
目次

The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive the growth of the market. However, the market growth would be challenged by stringent regulatory guidelines, emergence of alternative drug delivery methods and manufacturing complexity and high operational cost. A few notable trends may include accelerating prevalence of chronic diseases, growing adoption of self-injectable devices, upswing in drug shortages and advancements in technology.

Depending on the type, the global injectables market can be bifurcated into two main categories: innovator and generic. Further, generic injectables market can be split into Anti-Infectives (AI), Antineoplastics + Immunomodulators (AN+IM), Alimentary Tract + Metabolic (AT+Mb), Blood Related (BR), Central Nervous System (CNS), Musculoskeletal (Msk) and others, on the basis of therapy.

The fastest growing regional market is North America due to the improvements in healthcare infrastructure coupled with growing demand for injectables on account of high presence of a large number of patients with chronic diseases such as diabetes and arthritis which require frequent drug dosing and increasing research and development activities for the development of innovative injectables drugs. However, the market experienced a neutral growth due the outbreak of COVID-19 which moderately affected the production and clinical trials of various drugs.

Scope of the report:

  • The report provides a comprehensive analysis of the global injectables market segmented on the basis of type and region.
  • The major regional and country markets (North America, Europe, China, India and Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, Pfizer Inc., Fresenius SE & Co. KGaA, Baxter International Inc., Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.) and Hikma Pharmaceuticals PLC) are also presented in detail.

Key Target Audience:

  • Injectable Drug Manufacturers & Distributers
  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies
  • End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers & Others)
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Parenteral Route of Drug Administration
  • 1.3 Types of Parenteral Routes of Administration
  • 1.4 Formulation of Injectable
  • 1.5 Factors Favoring the Absorption of Injectable Drugs
  • 1.6 Types of Injectable Drug Products
  • 1.7 Advantages of Injectable Drugs

2. Impact of COVID-19

  • 2.1 Growing Investments in the R&D Pipeline of Injectables
  • 2.2 Surging Adoption of Plasma Therapy
  • 2.3 Rising Usage of Smart Syringes
  • 2.4 Accelerating Vaccine Production

3. Global Market Analysis

  • 3.1 Global Injectables Market by Value
  • 3.2 Global Injectables Market Forecast by Value
  • 3.3 Global Injectables Market by Type
    • 3.3.1 Global Innovator Injectables Market by Value
    • 3.3.2 Global Innovator Injectables Market Forecast by Value
    • 3.3.3 Global Generic Injectables Market by Value
    • 3.3.4 Global Generic Injectables Market Forecast by Value
    • 3.3.5 Global Generic Injectables Market by Therapy
    • 3.3.6 Global Anti-Infective Injectables Market by Value
    • 3.3.7 Global Anti-Infective Injectables Market Forecast by Value
    • 3.3.8 Global Antineoplastic+ Immunomodulator Injectables Market by Value
    • 3.3.9 Global Antineoplastic+ Immunomodulator Injectables Market Forecast by Value
    • 3.3.10 Global Alimentary Tract + Metabolic Injectables Market by Value
    • 3.3.11 Global Alimentary Tract + Metabolic Injectables Market Forecast by Value
    • 3.3.12 Global Blood Related Injectables Market by Value
    • 3.3.13 Global Blood Related Injectables Market Forecast by Value
    • 3.3.14 Global Central Nervous System Injectables Market by Value
    • 3.3.15 Global Central Nervous System Injectables Market Forecast by Value
    • 3.3.16 Global Musculoskeletal Injectables Market by Value
    • 3.3.17 Global Musculoskeletal Injectables Market Forecast by Value
  • 3.4 Global Injectables Market by Region
  • 3.5 Global Generic Injectables Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Injectables Market by Value
    • 4.1.2 North America Injectables Market Forecast by Value
    • 4.1.3 North America Generic Injectables Market Forecast by Value
    • 4.1.4 The U.S. Injectables Market by Value
    • 4.1.5 The U.S. Injectables Market Forecast by Value
    • 4.1.6 The U.S. Injectables Market by Type
    • 4.1.7 The U.S. Innovator Injectables Market Forecast by Value
    • 4.1.8 The U.S. Generic Injectables Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Injectables Market by Value
    • 4.2.2 Europe Injectables Market Forecast by Value
    • 4.2.3 Europe Generic Injectables Market Forecast by Value
  • 4.3 China
    • 4.3.1 China Injectables Market by Value
    • 4.3.2 China Injectables Market Forecast by Value
    • 4.3.3 China Injectables Market by Type
    • 4.3.4 China Generic Injectables Market Forecast by Value
    • 4.3.5 China Innovator Injectables Market Forecast by Value
  • 4.4 India
    • 4.4.1 India Injectables Market by Value
    • 4.4.2 India Injectables Market Forecast by Value
    • 4.4.3 India Generic Injectables Market Forecast by Value
  • 4.5 RoW
    • 4.5.1 RoW Injectables Market by Value
    • 4.5.2 RoW Injectables Market Forecast by Value
    • 4.5.3 RoW Generic Injectables Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Geriatric Population
    • 5.1.2 Upsurge in Demand for Convenient Drug Delivery
    • 5.1.3 Expanding Use of Biologics
    • 5.1.4 Rising Healthcare Expenditure
    • 5.1.5 Surging Incidence of Cancer Cases
  • 5.2 Key Trends and Developments
    • 5.2.1 Accelerating Prevalence of Chronic Diseases
    • 5.2.2 Growing Adoption of Self-Injectable Devices
    • 5.2.3 Upswing in Drug Shortages
    • 5.2.4 Advancements in Technology
  • 5.3 Challenges
    • 5.3.1 Stringent Regulatory Guidelines
    • 5.3.2 Emergence of Alternative Drug Delivery Methods
    • 5.3.3 Manufacturing Complexity & High Operational Cost

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Market Capitalization Comparison of Key Players
    • 6.1.3 R&D Comparison of Key Players
  • 6.2 North America Market
    • 6.2.1 The U.S. Generic Injectables Market Value Share by Key Players
    • 6.2.2 The U.S. Generic Injectables Market Volume Share by Key Players

7. Company Profiles

  • 7.1 Novartis International AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Pfizer Inc.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Fresenius SE & Co. KGaA
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Baxter International Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Shanghai Fosun Pharmaceutical Group Co. Ltd. (Gland Pharma Ltd.)
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Hikma Pharmaceuticals PLC
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies